News - Biomira Inc.
BELLEVUE, WA, Dec. 11 /PRNewswire-FirstCall/ -- Oncothyreon Inc. (TSX:ONY) today announced that its common stock will begin trading on the Nasdaq Global Market under the symbol ONTY and on the Toronto Stock Exchange under the symbol ONY at the opening of trading today. Oncothyreon Inc.
EDMONTON, Sept. 5 /PRNewswire-FirstCall/ -- Biomira Inc. (TSX: BRA) today announced the presentation of three-year survival results from a randomized Phase II trial of the Stimuvax(R) MUC-1 vaccine in non-small cell lung cancer (NSCLC).
EDMONTON, Aug. 28 /PRNewswire-FirstCall/ -- Biomira Inc. (TSX: BRA) today announced that the first patient has been enrolled in a Phase 1 clinical trial of PX-478 in patients with advanced metastatic cancer.
EDMONTON, Aug. 8 /PRNewswire-FirstCall/ -- Biomira Inc. (TSX: BRA) today announced the signing of amended and restated collaboration and supply agreements related to Stimuvax(R) with Merck KGaA of Darmstadt, Germany.